This information was published on 2025-02-24T00:07:16 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2484641 |
| (220) |
23 Sep 2024
|
| (511) (510) |
Class 5
pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin |
| (540) | MYXREDLIN |
| (550) | Word |
| (730) |
Baxter International Inc.
|
| (750) |
Maxwells Patent & Trade Mark Attorneys Pty Ltd
|
Find out more about publications on the About page.